Cargando…
Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
Phenylketonuria (PKU) is a genetic metabolic disease in which the decrease or loss of phenylalanine hydroxylase (PAH) activity results in elevated, neurotoxic levels of phenylalanine (Phe). Due to many obstacles, PAH enzyme replacement therapy is not currently an option. Treatment of PKU with an alt...
Autores principales: | Bell, Sean M., Wendt, Dan J., Zhang, Yanhong, Taylor, Timothy W., Long, Shinong, Tsuruda, Laurie, Zhao, Bin, Laipis, Phillip, Fitzpatrick, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345807/ https://www.ncbi.nlm.nih.gov/pubmed/28282402 http://dx.doi.org/10.1371/journal.pone.0173269 |
Ejemplares similares
-
Pharmacodynamics, safety, tolerability and pharmacokinetics of a single oral dose of an engineered phenylalanine ammonia-lyase in patients with phenylketonuria
por: Fazio, Timothy Nicholas, et al.
Publicado: (2023) -
Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
por: Diaz-Trelles, Ramon, et al.
Publicado: (2022) -
Fungal and Plant Phenylalanine Ammonia-lyase
por: Hyun, Min Woo, et al.
Publicado: (2011) -
Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat
por: Thiyagarajan, Karthikeyan, et al.
Publicado: (2016) -
Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2020)